Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul B Watkins

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2022
Quantitative Systems Toxicology and Drug Development: The DILIsym ExperiencePaul B Watkins
Digestive Diseases (Basel, Switzerland)|July 11, 2015
How to Diagnose and Exclude Drug-Induced Liver InjuryPaul B Watkins
Seminars in Liver Disease|October 15, 2009
Biomarkers for the diagnosis and management of drug-induced liver injuryPaul B Watkins
Advances in Pharmacology (San Diego, Calif.)|July 17, 2019
Idiosyncratic drug-induced liver injury in patients: Detection, severity assessment, and regulatory implicationsPaul B Watkins
Toxicologic Pathology|April 5, 2005
Idiosyncratic liver injury: challenges and approachesPaul B Watkins
The American Journal of Gastroenterology|May 31, 2008
Drug-induced liver injury networkPaul B Watkins
CPT: Pharmacometrics & Systems Pharmacology|April 28, 2018
Improving Interpretation of New and Old Serum Biomarkers of Drug-Induced Liver Injury Through Mechanistic ModelingPaul B Watkins
Hepatology (Baltimore, Md.)|January 20, 2005
Insight into hepatotoxicity: The troglitazone experiencePaul B Watkins
Clinical Pharmacology and Therapeutics|December 15, 2021
Liver Injury Due to Drugs and Viruses: Mechanistic Similarities and Implications for AAV Gene TherapyPaul B Watkins
Clinics in Liver Disease|November 23, 2019
Quantitative Systems Toxicology Approaches to Understand and Predict Drug-Induced Liver InjuryPaul B Watkins
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2022
Quantitative Systems Toxicology and Drug Development: The DILIsym ExperiencePaul B Watkins
Digestive Diseases (Basel, Switzerland)|July 11, 2015
How to Diagnose and Exclude Drug-Induced Liver InjuryPaul B Watkins
Seminars in Liver Disease|October 15, 2009
Biomarkers for the diagnosis and management of drug-induced liver injuryPaul B Watkins
Advances in Pharmacology (San Diego, Calif.)|July 17, 2019
Idiosyncratic drug-induced liver injury in patients: Detection, severity assessment, and regulatory implicationsPaul B Watkins
Toxicologic Pathology|April 5, 2005
Idiosyncratic liver injury: challenges and approachesPaul B Watkins
The American Journal of Gastroenterology|May 31, 2008
Drug-induced liver injury networkPaul B Watkins
CPT: Pharmacometrics & Systems Pharmacology|April 28, 2018
Improving Interpretation of New and Old Serum Biomarkers of Drug-Induced Liver Injury Through Mechanistic ModelingPaul B Watkins
Hepatology (Baltimore, Md.)|January 20, 2005
Insight into hepatotoxicity: The troglitazone experiencePaul B Watkins
Clinical Pharmacology and Therapeutics|December 15, 2021
Liver Injury Due to Drugs and Viruses: Mechanistic Similarities and Implications for AAV Gene TherapyPaul B Watkins
Clinics in Liver Disease|November 23, 2019
Quantitative Systems Toxicology Approaches to Understand and Predict Drug-Induced Liver InjuryPaul B Watkins
Pageof 18